Filter
423
Filtered Results: 423
Text search:
The
Center
for
Health
Market
Innovations.
Featured
Recommendations
29
New Publications
112
Language
Document type
No document type
208
Studies & Reports
121
Guidelines
39
Strategic & Response Plan
26
Manuals
20
Training Material
4
Situation Updates
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
Global
24
Kenya
14
Ethiopia
10
India
10
Sierra Leone
9
Liberia
9
Nigeria
8
Syria
8
Nepal
7
Rwanda
7
Africa
7
Congo, Democratic Republic of
6
Uganda
6
Philippines
6
Bangladesh
6
Malawi
6
Ukraine
6
Latin America and the Carribbean
6
Senegal
5
Zambia
5
Myanmar / Burma
5
Western and Central Europe
5
Asia
5
Eastern Europe
5
Guinea
4
Ghana
4
Cambodia
4
Thailand
4
Mozambique
4
Colombia
4
Cameroon
3
Haiti
3
South Sudan
3
Jordan
3
Indonesia
3
South–East Asia Region
3
Burkina Faso
2
USA
2
Zimbabwe
2
Germany
2
Lebanon
2
Turkey
2
Egypt
2
China
2
South Africa
2
Central African Republic
2
Lesotho
2
Mali
1
Somalia
1
Iraq
1
Tanzania
1
Argentina
1
Peru
1
Bolivia
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Venezuela
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Moldova
1
Georgia
1
Turkmenistan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
142
Key Resources
34
Public Health
27
Clinical Guidelines
15
Women & Child Health
8
Capacity Building
4
Pharmacy & Technologies
4
Toolboxes
Planetary Health
40
COVID-19
32
AMR
27
HIV
24
Mental Health
20
Global Health Education
20
TB
17
Health Financing Toolbox
17
Disability
14
Conflict
12
Ebola
9
NTDs
9
Natural Hazards
8
Caregiver
8
Rapid Response
6
Refugee
6
Pharmacy
6
NCDs
6
Social Ethics
3
Typhoon
1
Desk Review and Recommendations for Private Sector Engagement
Background paper 9
The Independent Panel for Pandemic Preparedness and Response
May 2021
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many ...
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten...
Ethiopia met the MDG target for drinking water access with a unique and high degree of success. The magnitude of ... country’s success in providing improved drinking water to nearly half of its population in 25 years despite its diversity, size, and challenges cannot be overstated. This case study documents the progress of the Ethiopian WASH sector from 1990 to 2015, and analyzes the impact of local systems created in Ethiopia to respond to water and sanitation challenges.
Background Paper prepared for the 2015 Global Assessment Report on Disaster Risk Reduction
The aim of this paper is to help bring voluntary s...
The aim of this paper is to help bring voluntary s...
The International Forum of Indigenous Women (IIWF) has prepared this report in order to have a
document for analysis and systematization of the im...
A two-week mission was conducted by WASH and quality UHC technical experts from WHO headquarters and supported by the WHO Ethiopia Country Office (WASH and health systems teams) in July 2016, to und...
The NGO Safety and Security Training Report provides a narrative of the research findings, an updated curriculum, and guidance tools for training. ...
Application for Program Design in the Europe and Eurasia Region
Nationally, Senegal met the MDG target for water supply access. It did this by engaging the public and private sectors to effectively invest and re...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with inf...
This guide is intended to support teams working directly with communities during the Covid-19 pandemic. It provides general guidance on community engagement during outbreak responses, including how to support an integrated response, as well as outbr...
While many of the countries hit by the COVID-19 in the first few months of the year are now begi...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of ... deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisive role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
Conflicts and disasters, including pandemics, affect women and men in all their diversity differently, and women and girls often suffer the most. Crisis-related hardships combine and compound pre-existing disadvantages, ... example, they often cause women’s working conditions to worsen while increasing their overall workload and care responsibilities. At the same time, crises can give rise to changes that enable women to take up roles that were previously available only to men, and crises can open opportunities to address existing gender-based discrimination and violations of rights.
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which ... pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment of five leading vaccine manufacturers, AstraZeneca plc, BioNTech SE, Johnson & Johnson, Moderna Inc., and Pfizer Inc. It also includes for the first time an assessment of the two largest Chinese vaccine producers, China National Pharmaceutical Group Co., Ltd. (Sinopharm) and Sinovac Biotech Ltd. (Sinovac).
As of June 2019, the number of Venezuelans leaving their country reached 4 million, with Colombia, Peru, Chile, Ecuador and Brazil hosting the vast majority of Venezuelans in Latin America. ... end of the first half of the year was marked by the announcement of tighter immigration measures in Peru and Chile, which triggered a significant peak in flows from Venezuela entering Colombia, Ecuador and Peru. In response to this, UNICEF Country Offices activated contingency measures and capacities for registration and provision of services were rapidly increased, in coordination with relevant authorities, to face the increased demand.
